[ Price : $8.95]
FDA clears an ACON Laboratories 510(k) for its Flowflex Covid-19 Antigen Home Test, which was originally authorized for emergency ...[ Price : $8.95]
Federal Register notice: FDA classifies the container system for the processing and storage of red blood cell components under red...[ Price : $8.95]
FDA approves Takedas Adzynma, a recombinant protein product designed for prophylactic or on‑demand enzyme replacement therap...[ Price : $8.95]
The CDER Office of Therapeutic Biologics and Biosimilars recommends expiration dates for first interchangeable exclusivity for Boe...[ Price : $8.95]
Federal Register notice: FDA determines that Akorns Cogentin (benztropine mesylate) Injection (1 mg/1 mL) was not withdrawn due to...[ Price : $8.95]
CDER announces a reorganization of the Office of Pharmaceutical Quality effective 1/14/2024.[ Price : $8.95]
FDA tells healthcare providers about labeling updates to Becton Dickinsons (BD) Phasix and GalaFlex mesh products that discourage ...[ Price : $8.95]
FDA approves a PMA for the Recor Medical Paradise renal denervation system to treat hypertension.